Vitamin D serum level and CYP27B1-1260 promoter polymorphism in chronic hepatitis C patients treated with interferon / Essam Ali Mohamed Ali ; Supervised Olfat Gamil Shaker , Samar Ali Marzouk , Gamal Essmat
Material type:
- فى مرضى الالتهاب الكبدى الوبائى سى المعالجين بالانترفيرون CYP27B1-1260 مستوى فيتامين د فى مصل الدم و التعدد الجينى للنقطة [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.03.Ph.D.2014.Es.V (Browse shelf(Opens below)) | Not for loan | 01010110064375000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.03.Ph.D.2014.Es.V (Browse shelf(Opens below)) | 64375.CD | Not for loan | 01020110064375000 |
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Medical Biochemistry
Chronic infection with hepatitis C virus (HCV) is a huge problem both globally and at the level of the individual patient. The natural outcome and response to treatment in hepatitis C virus infection varies between individuals. We aimed to determine the incidence of vitamin D deficiency in patients with chronic hepatitis C. In addition, we evaluated associations of vitamin D (Vit D) serum levels as well as polymorphism within gene encoding 1Ü- hydroxylase with the virologic response of interferon - Alfa based treatment in patients chronically infected with HCV in Egypt. Blood samples were taken from 103 patients who are suffering from chronic hepatitis C disease and prepared for interferon treatment. Also 30 blood samples from controls were taken
Issued also as CD
There are no comments on this title.